LINC02330

Across TCGA pan-cancer cohorts, LINC02330 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC02330’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC02330 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02330 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, LUSC, and UCEC are the cancer types where LINC02330 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02330 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	All	−0.254	<.001	5	view →
LUSC	Male	All	−0.184	<.001	2	view →
UCEC	All	All	−0.121	.023	2	view →
LIHC	All	All	+0.018	.015	2	view →
THCA	All	All	−0.011	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC02330–LUAD

Open the LUAD breakdown →